Genmab AS (GMAB): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 24.07.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 37,96 US Dollar | 4 | 1 | 4 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 613.935.890 | 1,25 | 3,62 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Genmab AS
Mitarbeiter 3.088
Handelsplatz NASDAQ
Ticker Symbol GMAB
IPO Datum 2009-06-01
Adresse Carl Jacobsens Vej 30, Copenhagen, Denmark, 2500
Webseite https://www.genmab.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Jan G.J. van de Winkel Ph.D. | Co-Founder, President & CEO |
| 2 | Mr. Anthony Pagano CPA | Executive VP & CFO |
| 3 | Mr. Rayne Waller | Executive VP & Chief Technical Operations Officer |
| 4 | Mr. Gregory David Emil Mueller | Executive VP, General Counsel & Chief Legal Officer |
| 5 | Mr. Christopher Cozic | Executive VP & Chief People Officer |
| 6 | Dr. Martine J. van Vugt Ph.D. | Executive VP & Chief Strategy Officer |
| 7 | Mr. Martin Schultz | Senior Director, Head of Development Business Partnership & Strategy and Director |
| 8 | Dr. Judith V. Klimovsky M.D. | Executive VP & Chief Development Officer |
| 9 | Dr. Tahamtan Ahmadi M.D., Ph.D. | Executive VP, Chief Medical Officer & Head of Experimental Medicines |
| 10 | Dr. Mijke Zachariasse Ph.D. | VP, Head of Antibody Research Materials & Director |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Orbis Allan Gray Ltd | 2,11% | 0,37 Mrd. USD |
| 2 | AllianceBernstein L.P. | 1,56% | 0,28 Mrd. USD |
| 3 | Paradigm Biocapital Advisors LP | 1,30% | 0,23 Mrd. USD |
| 4 | Arrowstreet Capital Limited Partnership | 0,81% | 0,14 Mrd. USD |
| 5 | BlackRock Inc | 0,74% | 0,13 Mrd. USD |
| 6 | Renaissance Technologies Corp | 0,72% | 0,13 Mrd. USD |
| 7 | Deep Track Capital, LP | 0,60% | 0,11 Mrd. USD |
| 8 | Harding Loevner L.P. | 0,53% | 0,09 Mrd. USD |
| 9 | Deerfield Management Co | 0,40% | 0,07 Mrd. USD |
| 10 | First Trust Advisors L.P. | 0,40% | 0,07 Mrd. USD |
| 11 | Two Sigma Investments LLC | 0,38% | 0,07 Mrd. USD |
| 12 | Morgan Stanley - Brokerage Accounts | 0,36% | 0,06 Mrd. USD |
| 13 | Federated Hermes Inc | 0,20% | 0,04 Mrd. USD |
| 14 | Franklin Resources Inc | 0,19% | 0,03 Mrd. USD |
| 15 | Pictet Asset Manangement SA | 0,18% | 0,03 Mrd. USD |
| 16 | Brandywine Global Investment Mgmt LLC | 0,17% | 0,03 Mrd. USD |
| 17 | FMR Inc | 0,16% | 0,03 Mrd. USD |
| 18 | Northern Trust Corp | 0,15% | 0,03 Mrd. USD |
| 19 | The Goldman Sachs Group Inc | 0,15% | 0,03 Mrd. USD |
| 20 | Millennium Management LLC | 0,13% | 0,02 Mrd. USD |